Home › Funds › Nicholas Investment Partners, LP › AXSM
Nicholas Investment Partners, LP position in AXSM
AXSOME THERAPEUTICS INC. · Health Care
Nicholas Investment Partners, LP reported holding 72,060 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$13.3M, representing 0.99% of its reported portfolio and ranking #31 among its reported holdings. Nicholas Investment Partners, LP has disclosed AXSM holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Nicholas Investment Partners, LP's AXSM position evolved
Nicholas Investment Partners, LP first disclosed a stake in AXSM in Q3 2023 at 394,980 shares (US$27.6M). Across 12 filings, Nicholas Investment Partners, LP increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 72,060 shares valued at US$13.3M — a reduction of -26,914 shares quarter over quarter.. Notable position changes include a 79% trim in Q4 2023 (shares were roughly flat over the following quarter), a 330% increase in Q1 2025 (shares fell 10% over the following quarter), a 88% increase in Q4 2025 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 394.98K | $27.61M | New |
| Q4 2023 | 82.64K | $6.58M | Reduce |
| Q1 2024 | 36.82K | $2.94M | Reduce |
| Q3 2024 | 10.13K | $910.83K | New |
| Q4 2024 | 10.13K | $857.52K | Hold |
| Q1 2025 | 43.57K | $5.08M | Add |
| Q2 2025 | 42.15K | $4.40M | Reduce |
| Q3 2025 | 48.66K | $5.91M | Add |
| Q4 2025 | 91.56K | $16.72M | Add |
| Q1 2026 | 81.48K | $13.77M | Reduce |
| Q2 2026 | 98.97K | $24.23M | Add |
| Q3 2026 | 72.06K | $13.29M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AXSM and 13F data
AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 43 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$147.5M), ALETHEA CAPITAL MANAGEMENT, LLC (US$119.7M), Sofinnova Investments, Inc. (US$82.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AXSM
- Deep Track Capital, LP 800.00K sh · $147.51M · Q3 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 649.12K sh · $119.69M · Q3 2026
- Sofinnova Investments, Inc. 445.91K sh · $82.22M · Q3 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 254.28K sh · $62.24M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 300.10K sh · $55.34M · Q3 2026
- SAMLYN CAPITAL, LLC 289.25K sh · $53.33M · Q3 2026
More on Nicholas Investment Partners, LP
FAQ
How long has Nicholas Investment Partners, LP held AXSM?
Nicholas Investment Partners, LP has disclosed AXSM holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
What is Nicholas Investment Partners, LP's current position in AXSM?
As of Q3 2026, Nicholas Investment Partners, LP holds 72.06K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $13.29M, representing 0.99% of its reported portfolio and ranking #31.
Has Nicholas Investment Partners, LP been buying or selling AXSM?
In the latest 13F filing (Q3 2026), Nicholas Investment Partners, LP reduced its position in AXSM.
Which other funds hold AXSM?
Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Sofinnova Investments, Inc., among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.